Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03835533 |
| Title | Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations (PORTER) |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Parker Institute for Cancer Immunotherapy |
| Indications | |
| Therapies |
CDX-301 + INO-5151 + Nivolumab |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Angeles Clinic | Los Angeles | California | 90025 | United States | Details | |
| University of California San Francisco | San Francisco | California | 94158 | United States | Details | |
| Mount Sinai | New York | New York | 10029 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |